Mode
Text Size
Log in / Sign up

Vascular smooth muscle cell immune interactions drive remodeling across cardiovascular diseasesHow blood vessel cells drive heart disease and high blood pressure

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret VSMC-immune interactions as emerging mechanistic targets, not yet clinically actionable.

This narrative review examines the role of vascular smooth muscle cell (VSMC)-immune interactions in driving pathological vascular remodeling across several cardiovascular conditions. The authors analyze mechanisms in atherosclerosis, hypertension, aortic aneurysms and dissection, and arteritis/cardiomyopathy.

In atherosclerosis, the review focuses on metabolic reprogramming and epigenetic regulation as mechanisms underlying pathological VSMC remodeling. For hypertension, mechanosensitive mechanisms linking inflammation and contraction are emphasized. In aortic aneurysms and dissection, kinase-driven organelle stress pathways are highlighted, while microvascular dysfunction in arteritis and cardiomyopathy is linked to the secretory profile of VSMCs.

The review is purely mechanistic and does not report pooled effect sizes, clinical outcomes, or patient-level data. Limitations are not explicitly stated, but as a narrative review, the evidence is qualitative and hypothesis-generating. No safety data or practice recommendations are provided.

Clinicians should interpret these findings as early-stage mechanistic insights that may inform future therapeutic targets, but they do not yet support changes in clinical practice.

Your blood vessels are more than just pipes. The cells lining them, called vascular smooth muscle cells, play an active role in some of the most common and dangerous heart conditions. A new review of the latest research shows how these cells change their behavior in atherosclerosis, high blood pressure, and other diseases.

The review looked at how these cells get reprogrammed at a molecular level. In atherosclerosis, they shift their metabolism and gene activity in ways that make the disease worse. In high blood pressure, they become overly sensitive to mechanical forces, causing blood vessels to stiffen. In aortic aneurysms, stress inside the cells triggers dangerous changes.

This is a review article, meaning it summarizes findings from many studies. It doesn't include new experiments or patient data. So while it paints a clear picture of what scientists know so far, it doesn't prove any single cause or treatment. Still, it highlights how these cells are a key player in heart disease and could be a target for future therapies.

What this means for you:
Blood vessel cells change in ways that drive heart disease and high blood pressure.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
The dynamic interplay between vascular smooth muscle cells (VSMCs) and the immune microenvironment governs vascular repair and disease progression. This review systematically elucidates this multidimensional regulatory network. We primarily dissect the molecular mechanisms driving pathological VSMC remodeling, encompassing inflammatory signaling, regulated cell death, senescence-associated DNA damage, and organelle dysfunction. Furthermore, we delineate the bidirectional crosstalk connecting VSMCs with the extracellular matrix (ECM) and tissue-infiltrating leukocytes, notably macrophages, T cells, and neutrophils. Subsequently, we evaluate how this network dictates disease-specific pathophysiology across various cardiovascular diseases. Specifically, we analyze metabolic reprogramming and epigenetic regulation in atherosclerosis (AS), mechanosensitive inflammation-contraction coupling in hypertension, and kinase-driven organelle stress in aortic aneurysms and dissection. Moreover, we examine the secretory profile of VSMCs in pulmonary arterial hypertension (PAH) and their contribution to microvascular dysfunction in arteritis and cardiomyopathy. Ultimately, we highlight emerging therapeutic strategies targeting VSMC-immune interactions and discuss future translational prospects.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.